Literature DB >> 14982194

Laparoscopic prostatectomy: a promising option in the treatment of prostate cancer.

Andrew P Steinberg1, Inderbir S Gill.   

Abstract

It is still too soon to know if a laparoscopic approach is as good or even better than open surgical radical prostatectomy, the gold standard. Early data seem to suggest lower intraoperative bleeding rates, less postoperative pain, shorter hospital stay, and similar rates of oncologic cure, return to potency, and urinary continence.

Entities:  

Mesh:

Year:  2004        PMID: 14982194     DOI: 10.3949/ccjm.71.2.113

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

1.  Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Michael C Truss; Martin Burchardt; Thomas R Herrmann; Thilo Schwalenberg; Panagiotis Kallidonis; Evangelos N Liatsikos
Journal:  World J Urol       Date:  2007-03-02       Impact factor: 4.226

2.  Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.

Authors:  Medha Darshan; Qizhi Zheng; Helen L Fedor; Nicolas Wyhs; Srinivasan Yegnasubramanian; Peng Lee; Jonathan Melamed; George J Netto; Bruce J Trock; Angelo M De Marzo; Karen S Sfanos
Journal:  Prostate       Date:  2013-09-21       Impact factor: 4.104

3.  Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration.

Authors:  Jens-Uwe Stolzenburg; Johanna Wasserscheid; Robert Rabenalt; Minh Do; Thilo Schwalenberg; Alan McNeill; Costantinos Constantinides; Panagiotis Kallidonis; Roman Ganzer; Evangelos Liatsikos
Journal:  World J Urol       Date:  2008-09-07       Impact factor: 4.226

4.  Laparoscopic radical prostatectomy.

Authors:  Michael Lipke; Chandru P Sundaram
Journal:  J Minim Access Surg       Date:  2005-10       Impact factor: 1.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.